title: MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase.
abstract: MicroRNAs (miRs) have been demonstrated to be involved in the development and progression of osteosarcoma (OS), but the molecular mechanism still remains to be fully investigated. The present study investigated the function of miR-148a in OS, as well as its underlying mechanism. Our data showed that miR-148a was significantly downregulated in OS tissues compared to their matched adjacent normal tissues, and also in OS cell lines compared to normal human osteoblast cells. Low expression of miR-148a was significantly associated with tumor progression and a poor prognosis for OS patients. Rho-associated coiled-coil kinase 1 (ROCK1) was then identified as a target of miR-148a in Saos-2 and U2OS cells, and the expression of ROCK1 was significantly increased in OS tissues and cell lines. Moreover, the protein expression of ROCK1 was markedly reduced in miR-148a-overexpressing Saos-2 and U2OS cells, but significantly increased in miR-148a-downregulated Saos-2 and U2OS cells. Further investigation indicated that miR-148a had a suppressive effect on the proliferative, migratory, and invasive capacities of Saos-2 and U2OS cells. Moreover, overexpression of ROCK1 attenuated the inhibitory effects of miR-148a upregulation on the malignant phenotypes of Saos-2 and U2OS cells. In addition, overexpression of miR-148a significantly inhibited the tumor growth of U2OS cells in nude mice. Taken together, these data demonstrate that miR-148a acts as a tumor suppressor in OS, at least partly, via targeting ROCK1. Therefore, the miR-148a/ROCK1 axis may become a potential therapeutic target for OS.
authors.forename: HaiYan
authors.initials: H
authors.lastname: Yang
authors.forename: ZhiGang
authors.initials: Z
authors.lastname: Peng
authors.forename: ZhenZhen
authors.initials: Z
authors.lastname: Da
authors.forename: Xin
authors.initials: X
authors.lastname: Li
authors.forename: YeXiao
authors.initials: Y
authors.lastname: Cheng
authors.forename: BinBin
authors.initials: B
authors.lastname: Tan
authors.forename: Xin
authors.initials: X
authors.lastname: Xiang
authors.forename: HaiPing
authors.initials: H
authors.lastname: Zheng
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.forename: LanHua
authors.initials: L
authors.lastname: Chen
authors.forename: Ning
authors.initials: N
authors.lastname: Mo
authors.forename: XueXin
authors.initials: X
authors.lastname: Yan
authors.forename: Xiaolin
authors.initials: X
authors.lastname: Li
authors.forename: XiaoHua
authors.initials: X
authors.lastname: Hu
mesh_terms: D000328:Adult; D000818:Animals; D001859:Bone Neoplasms / Q000201:enzymology / Q000235:genetics*; D045744:Cell Line, Tumor; D005260:Female; D016147:Genes, Tumor Suppressor; D064593:Heterografts; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D035683:MicroRNAs / Q000235:genetics*; D012516:Osteosarcoma / Q000201:enzymology / Q000235:genetics*; D014162:Transfection; D055815:Young Adult; D054460:rho-Associated Kinases / Q000235:genetics* / Q000378:metabolism
chemical_list: C550570:MIRN148 microRNA, human; D035683:MicroRNAs; C515851:ROCK1 protein, human; D054460:rho-Associated Kinases